Insight Molecular Diagnostics

IMDX

Börsenwert 96,9 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Broadwood Capital New York	18,9 Mio. $	–	–	–
2	2 Vanguard Group Malvern, Pennsylvania	1,03 Mio. $	+39.012 $	+756	+4 %
3	3 Bridgeway Capital Management Houston, Texas	750.000 $	–	–	–
4	AG 4 Artal Group Luxembourg	375.000 $	–	–	–
5	5 BlackRock New York	166.000 $	–	–	–
6	6 Element Capital Management New York	114.000 $	-33.129 $	-642	-22 %
7	7 Millennium Management New York	79.000 $	-237.994 $	-4.612	-74 %
8	8 Destination Wealth Management Walnut Creek, California	74.000 $	+76.528 $	+1.483	Neu
9	9 Morgan Stanley New York	73.000 $	+47.836 $	+927	+174 %
10	10 Commonwealth Equity Services Waltham, Massachusetts	60.000 $	+62.337 $	+1.208	Neu
11	11 Williams Jones & Associates New York	38.000 $	-671 $	-13	-2 %
12	12 Geode Capital Management Boston, Massachusetts	38.000 $	-206 $	-4	-0,5 %
13	13 Northern Trust Chicago, Illinois	37.000 $	+12.075 $	+234	+46 %
14	14 Janney Montgomery Scott Philadelphia, Pennsylvania	30.000 $	+310 $	+6	+1 %
15	15 Royal Bank of Canada Toronto, Ontario, Canada	13.000 $	–	–	–
16	16 Bank of Montreal Toronto, Ontario, Canada	3.000 $	–	–	–
17	17 Carroll Financial Associates Charlotte, North Carolina	2.000 $	–	–	–
18	18 Carson Wealth (CWM LLC) Omaha, Nebraska	1.000 $	–	–	–
19	19 JP Morgan Chase New York	1.000 $	–	–	–
20	20 Ladenburg Thalmann Financial Services Miami, Florida	1.000 $	–	–	–
21	21 BNP Paribas Financial Markets Paris, France	392 $	–	–	–
22	22 Goldman Sachs New York	–	-47.000 $	-923	Geschlossen
23	23 Parametric Portfolio Associates Seattle, Washington	–	-32.000 $	-630	Geschlossen
24	24 Paloma Partners Greenwich, Connecticut	–	-27.000 $	-539	Geschlossen
25	25 Bank of America Charlotte, North Carolina	–	-8.000 $	-159	Geschlossen

Insight Molecular Diagnostics IMDX Börsenwert 96,9 Mio. $

Insight Molecular Diagnostics

IMDX

Börsenwert 96,9 Mio. $